Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
22.1M
-
Shares change
-
+1.52M
-
Total reported value, excl. options
-
$602M
-
Value change
-
+$39.3M
-
Put/Call ratio
-
1.34
-
Number of buys
-
51
-
Number of sells
-
-27
-
Price
-
$27.21
Significant Holders of Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) as of Q2 2015
100 filings reported holding KPTI - Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share as of Q2 2015.
Karyopharm Therapeutics Inc. - Common Stock, par value $0.0001 per share (KPTI) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.1M shares
of 126M outstanding shares and own 17.49% of the company stock.
Largest 10 shareholders include FMR LLC (5.35M shares), FRANKLIN RESOURCES INC (4.71M shares), Palo Alto Investors, LLC (1.73M shares), STATE STREET CORP (1.23M shares), BlackRock Fund Advisors (1.06M shares), Partner Fund Management, L.P. (822K shares), Sectoral Asset Management Inc (713K shares), VANGUARD GROUP INC (701K shares), ALLIANCEBERNSTEIN L.P. (584K shares), and Tekla Capital Management LLC (477K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.